loadpatents
Patent applications and USPTO patent grants for Ermann; Monika.The latest application filed is for "compounds for treatment of diseases related to dux4 expression".
Patent | Date |
---|---|
Compounds for treatment of diseases related to DUX4 expression App 20220226318 - De Maeyer; Joris ;   et al. | 2022-07-21 |
Compounds for treatment of diseases related to DUX4 expression App 20210177847 - De Maeyer; Joris ;   et al. | 2021-06-17 |
Compounds for treatment of diseases related to DUX4 expression Grant 10,973,820 - de Maeyer , et al. April 13, 2 | 2021-04-13 |
Bicyclic tetrahydrothiazepine derivatives useful for the treatment of neoplastic and/or infectious diseases Grant 10,472,341 - Ermann , et al. Nov | 2019-11-12 |
Compounds for treatment of diseases related to DUX4 expression App 20190175596 - de Maeyer; Joris ;   et al. | 2019-06-13 |
Bicyclic Tetrahydrothiazepine Derivatives Useful For The Treatment Of Neoplastic And/or Infectious Diseases App 20180170888 - ERMANN; Monika ;   et al. | 2018-06-21 |
Deubiquitinase inhibitors and methods for use of the same Grant 9,868,736 - Donato , et al. January 16, 2 | 2018-01-16 |
Deubiquitinase Inhibitors And Methods For Use Of The Same App 20160237082 - Donato; Nicholas J. ;   et al. | 2016-08-18 |
Compounds which modulate the CB2 receptor Grant 9,315,454 - Bartolozzi , et al. April 19, 2 | 2016-04-19 |
Amine and ether compounds which modulate the CB2 receptor Grant 8,957,063 - Cirillo , et al. February 17, 2 | 2015-02-17 |
Sulfonyl compounds which modulate the CB2 receptor Grant 8,846,936 - Hickey , et al. September 30, 2 | 2014-09-30 |
Compounds which modulate the CB2 receptor Grant 8,829,034 - Berry , et al. September 9, 2 | 2014-09-09 |
Compounds which selectively modulate the CB2 receptor Grant 8,735,430 - Bartolozzi , et al. May 27, 2 | 2014-05-27 |
Sulfonyl Compounds Which Modulate The Cb2 Receptor App 20130184315 - Hickey; Eugene Richard ;   et al. | 2013-07-18 |
Compounds which selectively modulate the CB2 receptor Grant 8,383,651 - Bartolozzi , et al. February 26, 2 | 2013-02-26 |
Compounds which selectively modulate the CB2 receptor Grant 8,372,874 - Bartolozzi , et al. February 12, 2 | 2013-02-12 |
Compounds Which Selectively Modulate The CB2 Receptor App 20130030022 - BARTOLOZZI; Alessandra ;   et al. | 2013-01-31 |
Therapeutic uses of compounds which selectively modulate the CB2 receptor Grant 8,362,039 - Bartolozzi , et al. January 29, 2 | 2013-01-29 |
Therapeutic uses of compounds which selectively modulate the CB2 receptor Grant 8,349,871 - Bartolozzi , et al. January 8, 2 | 2013-01-08 |
Compounds Which Modulate The Cb2 Receptor App 20120316173 - Bartolozzi; Alessandra ;   et al. | 2012-12-13 |
Tetrazole compounds which selectively modulate the CB2 receptor Grant 8,329,735 - Ermann , et al. December 11, 2 | 2012-12-11 |
Compounds which modulate the CB2 receptor Grant 8,299,111 - Berry , et al. October 30, 2 | 2012-10-30 |
Tetrazole Compounds Which Selectively Modulate The CB2 Receptor App 20120071529 - ERMANN; Monika ;   et al. | 2012-03-22 |
Sulfone Compounds Which Modulate The CB2 Receptor App 20120015988 - Hickey; Eugene Richard ;   et al. | 2012-01-19 |
Therapeutic Uses of Compounds Which Selectively Modulate The CB2 Receptor App 20120010184 - BARTOLOZZI; Alessandra ;   et al. | 2012-01-12 |
Therapeutic Uses of Compounds Which Selectively Modulate The CB2 Receptor App 20110312932 - BARTOLOZZI; Alessandra ;   et al. | 2011-12-22 |
Compounds which selectively modulate the CB2 receptor Grant 8,048,899 - Bartolozzi , et al. November 1, 2 | 2011-11-01 |
Amine and Ether Compounds Which Modulate The CB2 Receptor App 20110190256 - Cirillo; Pier Francesco ;   et al. | 2011-08-04 |
Compounds Which Selectively Modulate The CB2 Receptor App 20110136869 - Bartolozzi; Alessandra ;   et al. | 2011-06-09 |
Compounds Which Modulate The CB2 Receptor App 20110130431 - BERRY; Angela ;   et al. | 2011-06-02 |
Compounds which modulate the CB2 receptor Grant 7,935,715 - Berry , et al. May 3, 2 | 2011-05-03 |
Compounds which modulate the CB2 receptor Grant 7,928,123 - Berry , et al. April 19, 2 | 2011-04-19 |
Compounds Which Modulate the CB2 Receptor App 20110071127 - BERRY; Angela ;   et al. | 2011-03-24 |
Compounds Which Selectively Modulate The CB2 Receptor App 20110071196 - BARTOLOZZI; Alessandra ;   et al. | 2011-03-24 |
Diazepane Compounds Which Modulate The CB2 Receptor App 20100261708 - Cirillo; Pier Francesco ;   et al. | 2010-10-14 |
Compounds Which Selectively Modulate The CB2 Receptor App 20100081644 - BARTOLOZZI; Alessandra ;   et al. | 2010-04-01 |
Compounds Which Selectively Modulate The CB2 Receptor App 20100076029 - BARTOLOZZI; Alessandra ;   et al. | 2010-03-25 |
Compounds which modulate the CB2 receptor Grant 7,595,397 - Zindell , et al. September 29, 2 | 2009-09-29 |
Compounds which Modulate the CB2 Receptor App 20080081822 - Berry; Angela ;   et al. | 2008-04-03 |
Compounds Which Modulate The CB2 Receptor App 20080039464 - BERRY; Angela ;   et al. | 2008-02-14 |
Compounds Which Modulate The CB2 Receptor App 20070191340 - Zindell; Renee ;   et al. | 2007-08-16 |
Substituted heterocyclic compounds and methods of use App 20050070554 - Nunes, Joseph J. ;   et al. | 2005-03-31 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.